Twist Bioscience (TWST) | Stock Overview & Key Data
Twist Bioscience Performance Comparison
Stock Range
Today's Range
Low: $25.73
High: $27.16
on August 21, 2025
52 Week Range
Low: $24.28
High: $55.33
on August 7, 2025
on January 24, 2025
All-Time High: $214.07 on January 18, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.7B
EPS
-1.44
P/E Ratio (TTM)
-7.35
Forward P/E
-11.53
P/B Ratio
3.53
PEG Ratio
0.06
Div. Yield
N/A
ROE
-17.58%
Beta
2.368
Debt to Equity
19.48
Financial Highlights
Profitability
Gross Margin
53.40%
Operating Margin
-31.36%
Profit Margin
-23.52%
Returns and Earnings
Return on Assets (TTM)
-13.88%
Return on Equity (TTM)
-17.58%
EBITDA
$-119.5M
Net Income (TTM)
$-85.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$6.15
Quarterly Revenue Growth (YoY)
17.90%
Quarterly Earnings Growth (YoY)
17.91%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience TWST | 1.69B Small-cap | -8.22% | -23.87% | -7.02% | -35.92% | -41.58% | -39.37% | -38.58% | -61.61% |
| Thermo Fisher TMO | 184.10B Large-cap | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% | -20.19% | -14.18% | 13.97% |
| Danaher DHR | 151.04B Large-cap | -3.01% | 8.42% | 9.15% | -3.01% | -11.27% | -24.34% | -17.95% | 11.85% |
| Neogen NEOG | 1.22B Small-cap | 1.82% | 17.15% | -9.97% | -44.22% | -53.10% | -66.63% | -73.62% | -85.24% |
| Grail GRAL | 1.13B Small-cap | 3.01% | -3.49% | -11.51% | -18.61% | 84.99% | 115.12% | 126.74% | 126.74% |
| Opko Health OPK | 1.09B Small-cap | 2.22% | -1.43% | 6.15% | -17.86% | -4.83% | -14.29% | -40.26% | -58.68% |
Ownership & Short Interest
Insider Ownership
1.88%
Institutional Ownership
116.82%
Shares Short
10M
Short Ratio
11.50
Short % of Shares Outstanding
19.51%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Twist Bioscience Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Twist Bioscience would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TWST's 52-week high and low?
- In the last 52 weeks, Twist Bioscience reached a high of $55.33 (on January 24, 2025) and a low of $24.28 (on August 7, 2025).
- What is the market cap and P/E ratio for TWST?
- Curious about Twist Bioscience's size and valuation? Its market capitalization stands at 1.69B. When it comes to valuation, the P/E ratio (trailing twelve months) is -7.35, and the forward P/E (looking ahead) is -11.53.
- Does TWST pay dividends? If so, what's the yield?
- As for dividends, Twist Bioscience isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Twist Bioscience's main competitors or similar companies to consider before investing?
When looking at Twist Bioscience, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -20.19% -14.18% Danaher
DHR151.04B Healthcare Diagnostics & Research -24.34% -17.95% Neogen
NEOG1.22B Healthcare Diagnostics & Research -66.63% -73.62% Grail
GRAL1.13B Healthcare Diagnostics & Research 115.12% 126.74% Opko Health
OPK1.09B Healthcare Diagnostics & Research -14.29% -40.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Twist Bioscience Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Twist Bioscience's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -17.58%, the Debt to Equity ratio from the most recent quarter is 19.48, and its Gross Profit Margin stands at 53.40%.
- What is the recent revenue and earnings growth for TWST?
- Looking at Twist Bioscience's growth, its revenue over the trailing twelve months (TTM) was $362M. Compared to the same quarter last year (YoY), quarterly revenue grew by 17.90%, and quarterly earnings saw a YoY growth of 17.91%.
- How much of TWST stock is held by insiders and institutions?
- Wondering who owns Twist Bioscience stock? Company insiders (like executives and directors) hold about 1.88% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 116.82%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.